Related Experiment Video

Updated: Jun 11, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an

Michael Z David1, Robert S Daum

  • 1Department of Pediatrics and Department of Medicine, the University of Chicago, 5841 S. Maryland Ave., Chicago, IL 60637, USA. mdavid@medicine.bsd.uchicago.edu

Clinical Microbiology Reviews
|July 9, 2010
PubMed

Insights

Community-associated Methicillin-resistant Staphylococcus aureus (CA-MRSA) strains cause infections in healthy individuals, differing from hospital-acquired strains. This review covers CA-MRSA epidemiology, clinical syndromes, and prevention strategies.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Epidemiology

Background:

  • Staphylococcus aureus is a significant pathogen causing various infections, including skin and soft-tissue infections (SSTIs), pneumonia, and sepsis.
  • Methicillin-resistant Staphylococcus aureus (MRSA) was historically associated with healthcare settings.
  • Emergence of community-associated MRSA (CA-MRSA) strains has led to increased infections in the general population without traditional healthcare risk factors.

Purpose of the Study:

  • To review the epidemiology of CA-MRSA strains.
  • To describe the clinical spectrum of CA-MRSA infections.
  • To discuss therapeutic and preventive strategies for CA-MRSA infections.

Main Methods:

  • Literature review of studies on CA-MRSA.
  • Analysis of epidemiological data on CA-MRSA.
  • Synthesis of information on clinical presentations and treatment of CA-MRSA.

Main Results:

  • CA-MRSA strains are distinct from healthcare-associated MRSA, infecting different patient groups and causing varied clinical syndromes.
  • These strains exhibit unique antimicrobial susceptibility patterns and spread rapidly in community settings.
  • CA-MRSA infections range from asymptomatic colonization to severe, life-threatening conditions.

Conclusions:

  • CA-MRSA represents a significant public health challenge due to its distinct epidemiology and clinical impact.
  • Understanding CA-MRSA characteristics is crucial for effective management and prevention.
  • Further research into targeted therapies and community-based prevention is warranted.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...